LPS Induces Hyper-Permeability of Intestinal Epithelial Cells

Journal of Cellular Physiology

Volumn 232, Issue 2, 2017, Pages 381-390

  Bein, Amir ^a   Zilbershtein, Alexander ^a   Golosovsky, Michael ^a   Davidov, Dan ^a   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; OCCLUDIN; PROTEIN ZO1; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INTESTINE EPITHELIUM CELL; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; INTESTINE; METABOLISM; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

CELL LINE; CELL MEMBRANE PERMEABILITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; NF-KAPPA B; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TIGHT JUNCTIONS; TOLL-LIKE RECEPTOR 4; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84971343450     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25435     Document Type: Article

References (85)

1. Abraham C, Cho JH. 2009. Inflammatory bowel disease. N Engl J Med 361:2066–2078.
2. Afrazi A, Branca MF, Sodhi CP, Good M, Yamaguchi Y, Egan CE, Lu P, Jia H, Shaffiey S, Lin J, Ma C, Vincent G, Prindle T, Jr., Weyandt S, Neal MD, Ozolek JA, Wiersch J, Tschurtschenthaler M, Shiota C, Gittes GK, Billiar TR, Mollen K, Kaser A, Blumberg R, Hackam DJ. 2014. Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem 289:9584–9599.
3. Anderson JM, Van Itallie CM. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:G467–G475.
4. Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S. 2012. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 143:1006–1016. e4.
5. Bein A, Lubetzky R, Mandel D, Schwartz B. 2015. TIMP-1 inhibition of occludin degradation in Caco-2 intestinal cells: A potential protective role in necrotizing enterocolitis. Pediatr Res 77:649–655.
6. Bolin FP, Preuss LE, Taylor RC, Ference RJ. 1989. Refractive index of some mammalian tissues using a fiber optic cladding method. Appl Opt 28:2297–2303.
7. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, Martin MU, Mantovani A, Muzio M. 2002. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: A molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99:3427–3431.
8. Cario E, Podolsky DK. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010–7017.
9. Chan KL, Wong KF, Luk JM. 2009. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implications. World J Gastroenterol 15:4745–4752.
10. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692.
11. Curl CL, Bellair CJ, Harris T, Allman BE, Harris PJ, Stewart AG, Roberts A, Nugent KA, Delbridge LM. 2005. Refractive index measurement in viable cells using quantitative phase-amplitude microscopy and confocal microscopy. Cytometry A 65:88–92.
12. Daddaoua A, Martinez-Plata E, Ortega-Gonzalez M, Ocon B, Aranda CJ, Zarzuelo A, Suarez MD, de Medina FS, Martinez-Augustin O. 2013. The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-kappaB/MAPK activation. Food Chem 136:1288–1295.
13. Duizer E, Penninks AH, Stenhuis WH, Groten JP. 1997. Comparison of permeability characteristics of the human colonic Caco-2 and rat small intestinal IEC-18 cell lines. J Cont Rel 49:39–49.
14. Eutamene H, Theodorou V, Schmidlin F, Tondereau V, Garcia-Villar R, Salvador-Cartier C, Chovet M, Bertrand C, Bueno L. 2005. LPS-induced lung inflammation is linked to increased epithelial permeability: Role of MLCK. Eur Respir J 25:789–796.
15. Fanning AS, Anderson JM. 2009. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann NY Acad Sci 1165:113–120.
16. Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. 2015. How the intricate interaction among toll-Like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology. J Immunol Res 2015:489821.
17. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen A, Breglio K, Goo T, Hsu D, Xu R, Abreu MT. 2009. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 15:997–1006.
18. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, Nast CC, Lechago J, Xu R, Naiki Y, Soliman A, Arditi M, Abreu MT. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288:G1055–G1065.
19. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. 2006. Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Int Immunol 18:1655–1662.
20. Ghosh S, May MJ, Kopp EB. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Ann Rev Immunol 16:225–260.
21. Golosovsky M, Lirtsman V, Yashunsky V, Davidov D, Aroeti B. 2009. Midinfrared surface-plasmon resonance: A novel biophysical tool for studying living cells. J Appl Phys 105: 1–11.
22. Good M, Siggers RH, Sodhi CP, Afrazi A, Alkhudari F, Egan CE, Neal MD, Yazji I, Jia H, Lin J, Branca MF, Ma C, Prindle T, Grant Z, Shah S, Slagle D, Paredes J, Ozolek J, Gittes GK, Hackam DJ. 2012. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci USA 109:11330–11335.
23. Good M, Sodhi CP, Egan CE, Afrazi A, Jia H, Yamaguchi Y, Lu P, Branca MF, Ma C, Prindle T, Jr., Mielo S, Pompa A, Hodzic Z, Ozolek JA, Hackam DJ. 2015. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 8:1166–1179.
24. Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet 361:512–519.
25. Guo S, Al-Sadi R, Said HM, Ma TY. 2013. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182:375–387.
26. Halpern MD, Holubec H, Dominguez JA, Meza YG, Williams CS, Ruth MC, McCuskey RS, Dvorak B. 2003. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 284:G695–G702.
27. Hamada K, Shitara Y, Sekine S, Horie T. 2010. Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats. Cancer Chemother Pharmacol 66:1031–1038.
28. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N. 1995. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387–400.
29. Hartsock A, Nelson WJ. 2008. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 1778:660–669.
30. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, Scholmerich J, Herfarth H, Ray K, Falk W, Rogler G. 2002. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122:1987–2000.
31. Henry MC, Moss RL. 2009. Necrotizing enterocolitis. Ann Rev Med 60:111–124.
32. Hooper LV, Gordon JI. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115–1118.
33. Ivanov AI, Parkos CA, Nusrat A. 2010. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177:512–524.
34. Jilling T, Simon D, Lu J, Meng FJ, Li D, Schy R, Thomson RB, Soliman A, Arditi M, Caplan MS. 2006. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177:3273–3282.
35. Knut J, Hans A, Ingemar L, Bo L. 2000. Imaging surface plasmon resonance sensor based on multiple wavelengths: Sensitivity considerations. Rev Sci Instrum 71:3530–3538.
36. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, Dubowski TD, Sodhi CP, Hackam DJ. 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 179:4808–4820.
37. Lin PW, Stoll BJ. 2006. Necrotising enterocolitis. Lancet 368:1271–1283.
38. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, Tatevian N, Rhoads JM. 2009. Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297:G442–G450.
39. Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42:145–151.
40. Lucas A, Cole TJ. 1990. Breast milk and neonatal necrotising enterocolitis. Lancet 336:1519–1523.
41. Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA. 2002. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J 21:2180–2188.
42. Maeshima N, Fernandez RC. 2013. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol 3:3.
43. Marcotte R, Wang E. 2002. Replicative senescence revisited. The journals of gerontology Series A. Biol Sci Med Sci 57:B257–B269.
44. Martin CR, Walker WA. 2006. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med 11:369–377.
45. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. 2000. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20:915–921.
46. Medvedev AE, Kopydlowski KM, Vogel SN. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164:5564–5574.
47. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J Immunol 164:5998–6004.
48. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, Llanos A, Claud EC, Walker WA. 2011. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: An immature innate immune response. PLoS ONE 6:e17776.
49. Neal MD, Jia H, Eyer B, Good M, Guerriero CJ, Sodhi CP, Afrazi A, Prindle T, Jr., Ma C, Branca M, Ozolek J, Brodsky JL, Wipf P, Hackam DJ. 2013. Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors. PLoS ONE 8:e65779.
50. Neal MD, Sodhi CP, Jia H, Dyer M, Egan CE, Yazji I, Good M, Afrazi A, Marino R, Slagle D, Ma C, Branca MF, Prindle T, Jr., Grant Z, Ozolek J, Hackam DJ. 2012. Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. J Biol Chem 287:37296–37308.
51. Neu J, Walker WA. 2011. Necrotizing enterocolitis. N Engl J Med 364:255–264.
52. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S. 2000. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476–3479.
53. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. 2003. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170:3977–3985.
54. Park BS, Lee JO. 2013. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 45:e66.
55. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. 1997. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523–527.
56. Polissi A, Sperandeo P. 2014. The lipopolysaccharide export pathway in Escherichia coli: Structure, organization and regulated assembly of the Lpt machinery. Mar Drugs 12:1023–1042.
57. Quigley MA, Henderson G, Anthony MY, McGuire W. 2007. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 4:CD002971.
58. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615–625.
59. Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635–700.
60. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241.
61. Richardson WM, Sodhi CP, Russo A, Siggers RH, Afrazi A, Gribar SC, Neal MD, Dai S, Prindle T, Jr., Branca M, Ma C, Ozolek J, Hackam DJ. 2010. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 139:904–917. e1–6.
62. Rothwarf DM, Karin M. 1999. The NF-kappa B activation pathway: A paradigm in information transfer from membrane to nucleus. Sci STKE 1999: 1.
63. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577–594.
64. Schnabl KL, Van Aerde JE, Thomson AB, Clandinin MT. 2008. Necrotizing enterocolitis: A multifactorial disease with no cure. World J Gastroenterol 14:2142–2161.
65. Schulz HN, Jorgensen BB. 2001. Big bacteria. Ann Rev Microbiol 55:105–137.
66. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495–1499.
67. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149–1163.
68. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189:1777–1782.
69. Singh JC, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, Lodge JP, Felsburg PJ, Carding SR. 2005. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol 288:G514–G524.
70. Sodhi CP, Neal MD, Siggers R, Sho S, Ma C, Branca MF, Prindle T, Jr., Russo AM, Afrazi A, Good M, Brower-Sinning R, Firek B, Morowitz MJ, Ozolek JA, Gittes GK, Billiar TR, Hackam DJ. 2012. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143:708–718. e1–5.
71. Sodhi CP, Shi XH, Richardson WM, Grant ZS, Shapiro RA, Prindle T, Jr., Branca M, Russo A, Gribar SC, Ma C, Hackam DJ. 2010. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 138:185–196.
72. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotten CM, Laroia N, Ehrenkranz RA, Dudell G, Cristofalo EA, Meier P, Lee ML, Rechtman DJ, Lucas A. 2010. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 156:562–567. e1.
73. Turner JR. 2009. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799–809.
74. Tusell JM, Saura J, Serratosa J. 2005. Absence of the cell cycle inhibitor p21Cip1 reduces LPS-induced NO release and activation of the transcription factor NF-kappaB in mixed glial cultures. Glia 49:52–58.
75. Ulevitch RJ, Tobias PS. 1999. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 11:19–22.
76. Van Itallie CM, Fanning AS, Bridges A, Anderson JM. 2009. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 20:3930–3940.
77. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249–255.
78. Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434.
79. Yao H, Yang SR, Edirisinghe I, Rajendrasozhan S, Caito S, Adenuga D, O'Reilly MA, Rahman I. 2008. Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol 39:7–18.
80. Yashunsky V, Lirtsman V, Zilbershtein A, Bein A, Schwartz B, Aroeti B, Golosovsky M, Davidov D. 2012. Surface plasmon-based infrared spectroscopy for cell biosensing. J Biomed Optics 17:081409–081401.
81. Yazji I, Sodhi CP, Lee EK, Good M, Egan CE, Afrazi A, Neal MD, Jia H, Lin J, Ma C, Branca MF, Prindle T, Richardson WM, Ozolek J, Billiar TR, Binion DG, Gladwin MT, Hackam DJ. 2013. Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling. Proc Natl Acad Sci USA 110:9451–9456.
82. Zhang X, Wang T, Gui P, Yao C, Sun W, Wang L, Wang H, Xie W, Yao S, Lin Y, Wu Q. 2013. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IkappaBalpha signaling in human vascular endothelial cells. Oxid Med Cell Longev 2013:185715.
83. Zhu XL, Wang YJ, Yang Y, Yang RC, Zhu B, Zhang Y, Lin Y, Lu Y, Li XF, O'Byrne KT. 2012. Suppression of lipopolysaccharide-induced upregulation of toll-like receptor 4 by emodin in mouse proximal tubular epithelial cells. Mol Med Rep 6:493–500.
84. Zilbershtein A, Bein A, Lirtsman V, Schwartz B, Golosovsky M, Davidov D. 2014. Surface plasmon resonance-based infrared biosensor for cell studies with simultaneous control. J Biomed Optics 19:111608.
85. Zilbershtein A, Golosovsky M, Lirtsman V, Aroeti B, Davidov D. 2012. Quantitative surface plasmon spectroscopy: Determination of the infrared optical constants of living cells. Vib Spectrosc 61:43–49.